2021
DOI: 10.1016/j.toxrep.2021.08.007
|View full text |Cite
|
Sign up to set email alerts
|

Common contributing factors to COVID-19 and inflammatory bowel disease

Abstract: Graphical abstract

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
8
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 8 publications
(9 citation statements)
references
References 185 publications
(206 reference statements)
1
8
0
Order By: Relevance
“…U.S. dietary consumption activates the innate immune system and impairs adaptive immunity, leading to chronic inflammation and an impaired host defense against viruses [ 77 ]. The common contributing factors of chronic inflammation were suggested in COVID-19 and inflammatory bowel disease [ 80 ]. Obese persons are vulnerable to COVID-19 because obesity-induced expansion of adipocytes alters the function and architecture of adipose tissue.…”
Section: Discussionmentioning
confidence: 99%
“…U.S. dietary consumption activates the innate immune system and impairs adaptive immunity, leading to chronic inflammation and an impaired host defense against viruses [ 77 ]. The common contributing factors of chronic inflammation were suggested in COVID-19 and inflammatory bowel disease [ 80 ]. Obese persons are vulnerable to COVID-19 because obesity-induced expansion of adipocytes alters the function and architecture of adipose tissue.…”
Section: Discussionmentioning
confidence: 99%
“…2 .). The present approach is similar to the dot-product approach used in the IBD and GIC studies ( Kostoff et al, 2021 , 2022 ). A core literature query was defined for COVID-19, applied to PubMed, and the resultant retrieval (∼146,000 records with abstracts, covering 1/2020-11/2021) was imported into VantagePoint (VP) software ( www.theVantagePoint.com ).…”
Section: Methodsmentioning
confidence: 99%
“…The central component of our approach is identification and elimination of CFs to these myriad chronic diseases, although complementary treatments can be used for the disease reversal process when necessary. Our group also published two papers ( Kostoff et al, 2021 , 2022 ) showing the commonality of CFs that impact infectious and chronic diseases (COVID-19 and Inflammatory Bowel Disease (IBD) in the first study ( Kostoff et al, 2021 ), and COVID-19 and Gastrointestinal Cancer (GIC) in the second study ( Kostoff et al, 2022 )). The results of these two studies imply that our toxicology-based approach for preventing and reversing chronic diseases can be integrated successfully with the present virology-based approach to preventing and reversing communicable diseases (that exploit immune system dysfunction), such as COVID-19.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Further, our recent studies on common CFs between COVID-19 and selected chronic diseases 5,6 show that many of the CFs that enable or exacerbate COVID-19 also enable or exacerbate the selected chronic diseases studied (Inflammatory Bowel Disease, IBD; Gastrointestinal Cancer, GIC). Thus, while additional studies are required for a more complete picture, it appears that the methods we have developed for preventing or reversing chronic diseases may also be applicable to preventing infectious diseases.…”
Section: Introductionmentioning
confidence: 99%